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The  ECHO  (enteric cytopathogenic human orphan)  group of viruses was 
originally distinguished from  the  Coxsackie viruses  not  only bemuse  they 
could not be recovered by inoculation of human material into newborn mice 
but also because they lacked this pathogenicity even after enrichment of the 
population in tissue culture (1).  The prototype strain (Hill) of ECHO 9 virus, 
originally reported as human enteric or "HE" Type 3 virus (2) was not patho- 
genic for newborn mice after several passages in tissue culture. Seven other 
strains of ECHO 9 virus recovered from healthy children in Cincinnati and 
Mexico (3)  as well as the Quigley strain  (4)  recovered from a  patient with 
aseptic  meningitis in  West  Virginia,  also  lacked pathogenicity for newborn 
mice in tests carried out in this laboratory (5) after a varying number of pas- 
sages in tissue culture. 
However, many of the viruses isolated in tissue culture during the extensive 
epidemics of aseptic meningitis and febrile exanthem in Europe and Canada 
in  1955 and  1956 that were originally or subsequently shown to  be  related 
to  ECHO  9  were found to produce  paralysis in newborn mice with muscle 
lesions similar to those associated with the Coxsackie A  group of viruses  (4, 
6--13). These reports  indicated that the  original human specimens were not 
paralytogenic for mice; five investigators (6,  7, 9,  13,  14) listed a  total of 76 
stools or cerebrospinal fluids that were tested with negative results. After one 
or  more  tissue  cultures  passages,  Johnsson  (6)  found only  7  of  20  strains 
paralytogenic, Godtfredsen and von Magnus (9)  only 10 of 21,  while Tyrrell 
and Snell (8) found 9 of 10 and Laforest d  a/. (11)  and Brohl a  al. (13) indi- 
cated that all the strains they had tested (13 and 12 respectively) were paralyto- 
genic in mice. Godtfredsen and yon Magnus (9) found no correlation between 
the amount of virus contained in the tissue cultures of various strains and their 
paralytogenic activity. All of  these  observations raised  the  question of the 
factors  that  were  responsible  for  the  paralytogenic activity of some  tissue 
culture  passaged  strains  of  ECHO  9  virus.  It  was  especially  desirable  to 
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determine  whether  paralytogenic  activity was  a  property  of only a  few virus 
particles  that  might  be  more  readily  encountered  in  large  populations  in 
tissue cultures and perhaps  be selectively enriched under certain conditions. 
Accordingly  when  many  thousands  of  cases  of  ECHO  9  virus  disease  oc- 
curred in the United States in 1957  (15), we undertook a  quantitative study of 
the factors which determine  the presence or absence of paralytogenic activity 
for newborn mice in various strains of ECHO  9 virus. The results of this study 
(16),  reported  in  detail  in  the present  communication,  established  that  while 
some ECHO  9 viruses lack the capacity to multiply in the muscles of newborn 
mice,  others  can  multiply  slowly  so  that  only  very  large  doses  of  virus  can 
produce paralysis,  and still other virus particles can multiply so fast that even 
small initial inocula can produce  paralysis. 
Materials and Methods 
Viruses.--The ECHO 9 virus prototype (Hill), purified by the terminal dilution technique' 
was used in its 14th passage in monkey kidney tissue culture.  The history of the other virus 
strains is described in the text. 
10 per cent stool suspensions  were prepared  in 0.5 per cent lactalbumin hydrolysate  in 
Earle's solution (LHE medium)  containing 2000 units of penicillin, 2 nag. of  streptomycin, 
and 25 units of nystatin  (mycostatin) per ml. as described before (15).  Cerebrospinal fluids 
were used untreated. Tissue culture fluids from infected tubes were harvested as soon as the 
cytopathogenic effect was complete and used without further treatment.  All virus materials 
were stored at about -20°C. 
Tissue  Cultures.--Trypsinized  cynomolgus  monkey  kidney  tissue  cultures  were  used 
throughout  these studies prepared  and maintained as described elsewhere (15).  They were 
inoculated 6 to 12 days after preparation. 
Titrations in tissue culture were carried out by inoculating 0.2 ml. of tenfold dilutions in 
the gassed  LHE medium pH 7.5,  (the diluent used throughout these experiments), into 2 to 
5 tubes per dilution. These tubes were read every 2 days, the final reading being made 8 days 
after inoculation. Virus titers were calculated according to the method of Reed and Muench. 
Mice.--Swiss albino mice--less than 24 hours old, unless otherwise stated--were bought 
from a  local animal supply house. The mice were pooled, redistributed among the mothers, 
and then inoculated simultaneously with 0.02 ml. intracerebraily and with 0.05 ml. subcuta- 
neously in the interscapular region, each mouse receiving a total of 0.07 ml. In a few instances 
only 0.02 to 0.05 ml. of cerehrospinal fluid was inoculated subcutaneously in each mouse be- 
cause no more was available. In the "growth curve" experiments with the Hill and the A. B. 
strains each mouse received only 0.03  ml. subcutaneously,  except in one case mentioned in 
text. 
The mice were observed at least once a day and clinical manifestations as well as deaths 
were recorded. In order to permit a  proper follow-up of individual mice, each "suspect" or 
sick mouse was appropriately marked with a dye. The observation period was 21 days. 
Suspensions  for further work were prepared as follows: whole mice or mouse carcasses (i.e., 
whole mouse without skin, legs, and intestines) that had been frozen at -20°C., were ground 
in a mortar with alundum to a 20 per cent suspension  in LHE medium as used for prepara- 
tion of stool suspensions.  The suspensions  were centrifuged in an International  centrifuge 
(model U) at 2000 R.p.~r. for 20 minutes and the supernatant  fluids were stored at  -20°C. 
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EXPERIMENTAL 
Mouse Pathogenicity  of Original  Cerebrospinal Fluids or Stool Specimens  and 
of First  Tissue Culture  Passages in Rdation  to Concentration of 
Virus in Inoculum 
From the large number of specimens studied during the ECHO 9 epidemic 
in Milwaukee and Cincinnati (15)  we selected 14 cerebrospinal fluids and 25 
TABLE  I 
Mouse Pathogenicity of Original Cerebrospinal  Fluid and of First Tissue Culture Passage in 
Rdation to Concentration  of Virus in Inoculum 
Patient 
1.  D.T ................ 
2.  W.R ............... 
3.  S.K ................ 
4.  A.B ................ 
5.  M.M ............... 
6.  P.M ............... 
7.  D.S ................ 
8.  A.H ................ 
9.  C.M ............... 
10.  J.S ................. 
11.  P.H ............... 
12.  M.H ............... 
13.  C. McL  ............. 
14.  R.B ................ 
CSF--orlginal  CSF--KPI* 
TCD6o inoculated  Result  TED60 inoculated 
Log IO  Log lO 
2.4 
2.0 
1.9 
1.5 
1.0 
0.4 
0.4 
0.1 
?§ 
1.5 
1.0 
0.4 
0.4 
0.0 
O/6J/  7.0 
o/8  7.5 
o/6  6.5 
o/8  7.5 
o/6  6.5 
0/6  6. 5 
0/6  7.0 
0/6  7.0 
0/7  5.5 
o/8  6.0 
o/8  7.0 
0/6  6.0 
0/8  6.9 
0/8  6.0 
Result 
8/8 
8/8 
8/8 
8/8 
8/8 
8/8 
8/8 
8/8 
6/7 
8/8 
8/8 
8/8 
o/._~9 
8/8 
Note.--Patients 1 to 9 were from Milwaukee during a large epidemic; Nos. 10 to 14 were 
from Cincinnati where only sporadic cases were encountered. 
* KP1, first passage in monkey kidney tissue culture. 
:~ 0/6, No. of mice paralyzed 
No. inoculated 
§ Virus present but not enough CSF available for titration. 
stools which produced cytopathogenic effects in tissue culture so rapidly that 
they appeared  to  have  the  highest  original  concentrations  of  virus.  These 
specimens (cerebrospinal fluid undiluted, stools as 10 per cent suspensions) as 
well as the undiluted first passage tissue culture fluids were inoculated into 
groups of newborn mice and simnltaneously titrated in monkey kidney tissue 
culture. The results of these tests are presented in Tables I and II. 
Only 1 of the 39 original specimens was paralytogenl  c for suckling mice, but 
this specimen (Table II, No. 25) had to be excluded from our study,  because 954  VARIANTS  OF  ECHO  9  VIRUS 
the  paralytogenic  effect  was  caused  by  a  non-cytopathogenic  Coxsackie  A 
virus and not by the ECHO  9 virus that it contained. Actually then none of 38 
stool  or  cerebrospinal  fluid  specimens  produced  paralysis  in  newborn  mice. 
On the other hand, after one passage in monkey  kidney tissue culture,  only 6 
TABLE  II 
Mouse  Pathogenicity of Original Stool Suspensions  and of First Tissue  Culture Passage in 
Relation to Concentration of Virus in Inoculum 
All specimens from patients in Milwaukee 
Patient 
1.  F.M.B ............. 
2.  L.M. A ............. 
3.  D.S ................ 
4.  Th. G ............... 
5.  A.K ................ 
6.  D.C ................ 
7.  M. T. ............. 
8,  A.R ............... 
9.  Sc.N  .............. 
10.  J.P ............... 
11.  Fr. J. Jr  ............ 
12.  J. Hu  .............. 
13.  T.K  ............... 
14.  J.H  ............... 
15. M.S  ............... 
16.  M.P  .............. 
17.  R.W .............. 
18.  J. G. A ............ 
19.  E.K .............. 
20.  W.G.L ............ 
21.  L. S. Jr  ............ 
22.  R.Z  ............... 
23.  H.G .............. 
24,  A.N ............... 
25.  E.M .............. 
Stool--original 
Result 
Stool--KPi 
TCD6o inoculated 
Log 10 
2.1 
2.0 
1.8 
1.5 
1.5 
1.5 
1.0 
1.0 
1.0 
1.0 
1.0 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0/7 
0/8 
0/10 
0/8 
o/5 
o/5 
0/9 
0/8 
0/10 
o/s 
o/6 
O/6 
0/4 
0/9 
0/9 
0/9 
0/8 
0/9 
0/9 
o/8 
0/9 
o/6 
o/8 
o/6 
9/9* 
TCD~e inoculated 
Log 10 
6.0 
4.0 
4.7 
5.0 
5.0 
5.5 
4.2 
5.0 
5.5 
6.0 
8.0 
4.5 
4.9 
5.1 
5.5 
5.5 
6.5 
4.5 
4.6 
4.9 
5.0 
6.0 
6.5 
6.5 
4.5 
(6.3)~ 
Result 
7/7 
0/..27 
4/10 
2/9 
3/8 
6/9 
o/1_.2o 
6/8 
lo/lo 
8/8 
6/7 
9/9 
0/9 
0/J.q 
9/10 
9/9 
8/9 
7/9 
6/9 
o/..~s 
8/9 
9/9 
8/8 
7/8 
9/9 
4/8 
Legends same as in Table L 
* The paralysis in these mice was caused by a non-cytopathogeuic Coxsackie A virus that 
was present in addition to the ECHO 9. 
This culture fluid represents the fourth passage in monkey kidney tissue culture which 
eliminated the non-cytopathogeuic Coxsackie A virus, and the effect in mice was produced 
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of  the  38  strains  were  not  paralytogenic.  Histological  examination  of  the 
affected mice  demonstrated muscle lesions similar  to  those  seen  after Cox- 
sackie A virus infection. 
However, while the original material never had more than  250 TCDs0 of 
virus per inoculum, and in many instances it was only 1  to  10 TCD60,  the 
undiluted  tissue  culture  fluids  provided inocula with  1@  to  l0  s TCDs0  per 
mouse. Furthermore in tabulating the relation between the amount of virus 
contained in inocula of undiluted culture fluids of the 38 strains and the inci- 
dence  of  paralysis  in newborn  mice  it  was  found  (Table  III)  that  mouse 
pathogenicity was generally less with the smaller amounts of virus. Thus, four 
of the  six strains  that failed to paralyze mice provided inocula of only los 
TABLE III 
Relation between Amount of Virus in Inoculum of Undiluted First Passage Culture Fluid of 38 
Different Strains and Incidence of Paralysis in Newborn Mice 
TCD.. of virus inoculated 
Log 10 
4.0-4.9 
5.0-5.9 
6.0-6.9 
7.0-7.9 
8.0 
No. of strains in indicated 
range of virus concentration 
8 
10 
13 
6 
1 
No. of strains producing indicated effect  in mice 
All mice well  Only some mice 
paralyzed 
4  3 
1  7 
I  2 
--  I 
Altair,- 
1 
2 
lO 
5 
to  ]04.9 TCD60.  On the other hand,  with one exception all strains providing 
inocula of 10  e TCDso or more produced paralysis in newborn mice. 
Is Mouse Pathogenicity  of First Passage Culture Fluids Due to Larger Amounts 
of Virus or to Qualitative Differences in  Virus? 
To answer this question it was first of all necessary to determine the effect 
in newborn mice of decreasing amounts of virus in first passage tissue culture 
fluids of various strains. The results of titrations in mice with 5 of our strains 
are presented in Table IV. It may be seen that the paralytogenic activity dis- 
appeared when the concentration of virus in the inoculum fell below the  104 
to  106  TCDs0  level--different amounts  being  required  for  different strains. 
It is clear, therefore, why the original human specimens containing a maximum 
of  only  102 .4  TCD~0  per  inoculum  were  not  paralytogenic.  Apparently  no 
significant,  qualitative  change  occurred in  the  virus  as  a  result  of a  single 
passage in tissue culture, and the mouse pathogenicity of first passage tissue 
culture fluids may have been due only to the larger amounts of virus obtained. 956  VARIANTS  OF  ECHO  9  vmvs 
TABLE IV 
Is Mouse Pathogenicity  of First Passage Culture Fluid Due to Larger Amount of Virus or to 
Qualitative Differences in Virus~ 
CSF--original 
Strain 
TCDIo inocu. Effect  in mice  Isted 
1.  D. T ........  10  2.4  0/6 
2.  W. R ......  102 .0  0/8 
3.  S. K .......  10  ~'9  0/6 
4.  A. B .......  101"6  0/8 
5.  J. S ........  10  x'6  0/8 
10~ 
CSF--KPx--effect  in mice of indicated  amount 
(TED.) of virus 
102  101  lOe 
1/8 
7/7 
10/ 
O/lO 
0/8 
4/8 
lO  4  1o  t 
0/8 
0/8 
0/8 
O/8 
O/3  O/8 
o/8 
0/8 
o/8 
0/8 
0/8 
0/8 
0/8 
0/9 
* These mice received 10  7'b TCDbo. 
TABLE V 
Effect of Multiple Passages in Tissue Culture on Mouse Pathogenicity in Rdation to Amount 
of Virus Inoculated 
Effect in newborn  mice  of indicated  amount (Log 10 TCDt0 ) of virus 
of indicated  passage  in tissue culture 
Strain 
Passage I  Passage 5 
1.  L.M.A ......... 
2.  M.T ........... 
3.  D.S  ........... 
4.  T.K ........... 
4.0* 
O/7 
4.2 
O/tO 
4.7 
4/to 
4.9 
o/9 
6.0 
8/8 
6.3 
4/8 
6.8 
5/8 
6.0 
3/8 
4.0 
0/7 
4.3 
0/8 
4.8 
0/8 
4.0 
0/8 
5.  W. G.L  ........ 
6.  J.H ........... 
7.  C. McL  ........ 
4.9 
0/8 
5.1 
0/10 
6.9 
O/9 
6.9  4.9 
8/8  2/10 
6.8  5.8 
7/7  5/9 
6.9  4.9 
218  018 
2.0 
0/8 
2.8 
0/8 
2.0 
0/8 
2.9 
0/8 
4.8 
1/4 
2.9 
0/8 
2.8 
018 
* 4.0  Numerator indicates log 10 TCDw of virus inoculated 
0/7  Denominator indicates effect in mice (number  paralyzed  over  number  inocu- 
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Effect o/ Multiple Passages  in Tissue Culture  on Mouse Pathogenicity 
In order to study the effect of multiple tissue culture passages of ECHO 9 
viruses on mouse pathogenicity we selected seven strains which after a  single 
passage in tissue culture had little or no effect in mice. The subsequent pas- 
sages in tissue culture were carried out with undiluted culture fluid as inoculum. 
The culture fluids of the 5th passage were then titrated in mice and in tissue 
culture.  The results are presented in Table V. It can readily be seen that the 
higher incidence of mouse pathogenicity of the 5th passage culture fluids was 
TABLE VI 
Enhancement of Mouse Pathogenicity by Two Consecutive Passages of Virus in Newborn Mice 
Strain 
W.R. 
J.S. 
D.T. 
Material tested 
KP 1 
KP 1-MP 25 
KP 1 
KP I-MP 2 
KP 1 
KP 1-MP 2 
Effect  in mice of indicated amount (TCD~I)  of virus 
10  7 
s/J, 
8/_~s 
I0  i  I0  i 
018  018 
9/9  5/8 
s/s  t/j 
6/6  6/6 
t/_.s  o/to 
t6/i6  a/it 
10' 
I ~/.~Z  7 
i 
10/3 
i i i/7 
I 
0/8  0/8 
o/8  o/8 
~/ll  t/._88 
018  018 
o18  o/it 
l0  t 
0/8 
0/8 
O/8 
0/7 
* These mice were inoculated with 10  ¢'~ TCD60. 
:~ KP 1-MP 2,  first passage monkey kidney culture fluid submitted to two consecutive 
passages in newborn mice and suspension of carcass of mice in second passage used for tests. 
related  to  higher  concentrations  of virus  achieved  during  the  tissue  culture 
passages, since the number of TCD60 required  to produce paralysis remained 
about the same. This confirmed our earlier results which indicated  that mere 
passage  in  tissue  culture  did  not  favor  the  selection  of  mouse  pathogenic 
virus particles. 
Enhancement of Mouse Pathogenicity  by Consecutive Passages of Virus in Mice 
The next question  to be considered was why such large doses were needed 
to produce paralysis in mice. One could assume that among the large number 
of virus particles in the tissue culture fluid there was only a  small proportion 
of paralytogenlc particles,  and  that  only  these  multiplied  in  the  mice.  Ac- 
cording to this hypothesis one would expect that virus recovered from paralyzed 
mice would be paralytogenic in very small doses. 
Therefore,  the  first  tissue  culture  passages of four strains  were submitted 
to two mouse passages, and the 2nd mouse passage was then titrated in mice 
and  tissue  culture  (see  Tables  VI and  VII). Mter  two  mouse  passages,  the 
paralytogenic  activity  of  the  virus  increased  10 to  1000  times. Strain A. B. 958  VARIANTS OF ECHO 9  VmUS 
(Table  VII)  which  initially  required  an  inoculum  of  about  106  TCDs0  to 
paralyze 50 per cent of the mice, required only about  108 TCDs0 after two 
mouse passages,  and  after five consecutive passages  in mice, which  had no 
effect on the capacity of the virus to grow in tissue culture, the 50 per cent 
paralyzing dose was reduced to 20 TCDso. On the other hand, five consecutive 
tissue culture passages failed to alter the paralytogenic activity of this strain. 
Thus, while consecutive passages in mice resulted in a  progressive increase 
in mouse pathogenicity of ECHO 9 strains, it was also evident that relatively 
large doses of ECHO 9 virus were still required to produce paralysis after 2 
passages of some strains. Accordingly mere selection of fuUy pathogenic virus 
particles preexisting in the tissue culture fluids was not the correct explanation. 
TABLE VII 
Coraparati~e Effect on Mouse Pathogen~ity of Multiple Passages of Strain "A. B." in Monkey 
Kidney Tissue Culture and in Newborn Mir.e 
Ma~rhl~sted 
KP  1  ................ 
KP 5 ................ 
KP 1-MP 2 .......... 
KP 1-MP 5 ......... 
Effect  in mice  of indicated  amount (TCD~)  of virus 
10¢  10e  10s  I  10~  10s  ]  10s  I  10x  I  10° 
/_s  I  5/s  I  t/s  I  -  I  0/8  10/8  [0/9  I  - 
/7  15/20  a/7  0/8  0/7  0/8  0/8  - 
-  6/0  19/19  11~/15  I x2/16  10/i4]o/ts]o/s 
Legends same as in Table VI. 
Inapparent Multiplication of ECHO 9  Virus Strains in Mice 
Another approach to our problem was  suggested by studies on mice that 
were ill or had died of intercurrent disease, mostly diarrhea without any sign 
of paresis,  as a  rule later than  12  days after inoculation of original human 
material or first passage culture fluids (Table VIII). It is evident that multi- 
plication of ECHO 9 viruses occurred in mice inoculated with doses as low as 3 
TCD~0, regardless of whether the virus had previously been passaged in mice, 
or in tissue culture, or not at all. It appeared highly improbable that there was 
any  causal  relationship  between  the  illnesses  and  deaths  and  the  observed 
multiplication of ECHO 9 virus. Subsequently, it was shown that after inocu- 
lation of certain doses and strains of ECHO 9 virus in newborn mice multi- 
plication  occurred without  production  of paralysis.  Furthermore,  histologic 
examination  of  two  mice  9  days  after inoculation of  original  human  stool 
suspension revealed limited lesions in the striated muscle, although no signs of 
paresis were observed. 
In one instance, blind passage was carried out in newborn mice with material 
derived from a  mouse that was found dead 13 days after inoculation of stool H.  J.  EGGERS AND  A.  B.  SABIN  959 
suspension containing 10  ~ TCDs0 of ECHO 9 virus. All the mice in the litter 
inoculated with the original stool suspension exhibited diarrhea after the 12th 
day but none had weakness or paralysis. Histologic examination of two mice 
that died 14 and 17  days after inoculation revealed only rare minute loci in 
the  striated  muscles  suggestive  of  regional  involvement  of  a  few  isolated 
TABLE VIII 
Evidence of Mulliplication in Newborn Mice of Non-Paralyzlng Doses of ECHO 9 Virus Present 
in Ori inal Human Ma2erial, Tissue Culture, or Paralyzed Mice 
Material  inoculated 
Original  human stool 
or CSF 
Monkey kidney 
tissue culture 
passage 1 
KP I-MP 2 
M.G. 
F. M. B. 
M.T. 
J.P. 
M.S. 
¢c 
~c 
R.W. 
J.H. 
A.H. 
C.M. 
D.T. 
J.H. 
W.G. 
M.T. 
W.R. 
J.S. 
TCDse inoculated 
2.0 
2.! 
1.0 
1.0 
1.0 
0.5 
0.5 
0.5 
0.5 
0.5 
0.! 
75 
6.0 
5.1 
L.  4.9 
4.2 
2.3 
2.3 
Day of sacrifice 
~S)  or death (D) of 
individual  mouse* 
D 13 
D 20 
D  8 
D 12 
S  9 
D 17 
D 18 
D 19 
D 18 
D 20 
D 18 
D 18 
D  18 
S  19 
S  II 
D  20 
D 18 
D 14 
TCDH of virus re- 
covered per gm of 
carcass 
Log 10 
5.7 
2.2 
4.2 
<1.0 
2.2 
5.7 
1.7 
2.2 
<1.0 
<1.0 
<1.0 
<1.0 
3.7 
2.2 
6.2 
<I.0 
4.2 
6.2 
* The dead or sacrificed  mice had diarrheal  disease  and did not exhibit  paralysis. 
Virus was present but not enough CSF available for titration. 
muscle fibers. The mouse that was used for the second passage contained I0  ~.7 
TCD60  of virus per gm. and 103a TCDs0 was inoculated in each mouse. None 
exhibited weakness or paralysis and 2 mice were sacrificed for the third pas- 
sage.  Of  the  14  newborn  mice in  the  third  passage,  7  developed transitory 
weakness 9  to  11  days after inoculation. Two  days after onset of weakness 
107"I TCD~0 of ECHO 9 virus per gin. of mouse carcass was found. 
This experience shows that during blind passages of certain strains in mice 
enough  virus  with  increased  paralytogenic activity may  ultimately be  ac- 
cumulated and selected to permit isolation of virus without the use of tissue 
culture. 960  VARIANTS  O17 ECHO  9  VIRUS 
Why Are Large Doses of Virus Needed to Produce Paralysis in Mice? 
Once  the inapparent multiplication of some  ECHO  9  viruses  in mice  was 
established, the hypothesis was considered that for paralysis to occur the virus 
had to multiply up to a certain level within a certain time. If this "paralyzing 
level" were not reached within a specified time, because the dose was too small 
in  relation  to  the  rate  of  multiplication  of  a  particular  strain,  it  appeared 
possible  that  the  mouse  might  in  the  meantime  lose  its  susceptibility.  The 
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FIG.  1. Rate of growth of ECHO  9  v~s  (stre~  "A. B.')  in newborn mice after inocula- 
tion of ]azge  (10  ~)  paralyzing  and smaller  (10  4) non-para]yz;ng  doses of tissue culture-pas- 
saged virus and of small (10  ~.s) dose of paralyzing mouse-passaged virus. 
following  observations  were  in  favor  of  this  hypothesis.  All  paralyzed  mice 
which had been studied  thus far at the onset of paralysis had  10  s TCD60 of 
virus or more per mouse. Among several thousand mice inoculated with various 
ECHO  9  viruses,  almost all exhibited the first  signs of paralysis within 5  to 
10 days after inoculation, i.e., not beyond the first 11 days of life. Adult mice 
had been found insusceptible to ECHO 9 virus. 
For investigation of  this hypothesis we selected  the A.  B.  strain and first 
of all determined the rate of multiplication of the virus in first passage tissue 
culture fluid in two groups of mice;  one group inoculated with  the regularly H.  J.  EGGERS  AND  A.  B.  SABIN  961 
paralytogenic dose of 107 TCD~0, and the other with los TCDs0, a  dose that 
in  previous  tests  was  not  paralytogenic.  Each  group  comprised  about  50 
mice,  distributed  among  seven mothers.  Three mice from each  group  were 
harvested  at  various  intervals  after inoculation,  indicated  in  Fig.  1.  With 
few exceptions, when the three mice were handled separately, the combined 
weight of the three was recorded, and without discarding any part of the body 
all were ground together in a  mortar to give a  20 per cent suspension.  The 
centrifuged supernatant liquids were titrated in tissue culture using 4, mostly 
5, tubes per dilution. The virus titers in Fig.  1 represent TCDs0 per average 
weight of total mouse. 
The data shown in Fig.  1 indicate that after an initial disappearance of 98 
per cent of the infective virus,  there was a  steady, more or less exponential 
increase of virus in the mice inoculated with the larger dose until a  level of 
10s .7 TCDs0 was reached on the 3rd day after inoculation--2 days before the 
majority of the mice first exhibited paralysis.  There was  then a  further in- 
crease in virus up to a  level of 109.4 to 109'e at first onset of paralysis and a 
subsequent progressive drop. 
The "growth curve" obtained in mice inoculated with  104 TCDs0.followed 
the same course, but at a lower level. After an initial reduction of 98 per cent 
there was again a steady increase in amount of virus, but by the 4th day the 
virus  had multiplied  only up  to  106 TCD60 per  mouse.  Despite  subsequent 
multiplication to a peak level of 10s "6 TCDs0 by the 6th day, only 1 of 27 mice 
exhibited slight paresis  7  days after inoculation, at  which  time  that  mouse 
yielded l0  s.e TCD~0 while the unaffected mice yielded only 107.s TCDs0. 
Generally, the yield of virus on a  certain day in mice inoculated with  107 
TCD60  was  not attained until 3  days later in  the  mice  inoculated with  104 
TCDs0. During the logarithmic phase of reproduction the difference in titers 
between the two groups was constant at about 1000-fold. 
In  view  of  these  results,  it  became  necessary  to  determine  whether  the 
capacity of small doses of "mouse-adapted" virus  to produce paralysis was 
associated with more extensive and rapid multiplication. In a  "growth curve" 
experiment with  102 .s TCDs0 of the  more paralytogenic virus  selected by 5 
consecutive passages in mice, it was found that up to 4 days after inoculation 
it had multiplied about 1000 times more than the first tissue culture passage 
virus (Fig. 1). All 55 mice remaining on the 5th day had extensive paralysis. 
These experiments indicated  that  the  4th  day  after inoculation of  1-day 
old mice was a critical day on which virus multiplication had to reach a level 
of about  l0  s TCDs0  if paralysis  was  to  develop subsequently.  In  order  to 
determine whether there actually is a change of susceptibility in suckling mice 
at this time two litters of mice, 5 to 6 days of age, were inoculated with 107 
TCDs0 of first tissue culture passage of the A.  B. strain.  This was  approxi- 
mately the amount of virus found in 5- to 5-day old mice after inoculation 962  VARIANTS  OF  ECHO  9  VIRUS 
of 104 TCDs0 of the A. B. strain on the day of birth. For simultaneous control 
10  ~ TCD~0 were inoculated into 2 litters of mice less than 24 hours old (see 
Table IX). All the newborn mice developed extensive paralysis within 4 to 5 
days and 8 of 11 died. On the other hand, none of the sixteen 5- to 6-day old 
mice developed weakness or paralysis and only one mouse had the "suspect" 
look  sometimes  seen  before appearance  of paralysis,  but  no  progression to 
paresis was observed. The importance of age of a suckling mouse in determining 
its response to ECHO 9 virus was confirmed in a  similar test with  "mouse- 
adapted" virus (Table IX). 
These  data  indicated  that  speed  of  multiplication,  which  may  perhaps 
mean  only greater yield per infected cell,  determined the paralytogenic ac- 
tivity of a  given population of ECHO  9 virus particles in newborn mice. If 
TABLE IX 
Res~tance of 5 to 6 Day Old Mice to Paralytogeni¢, Effect of Large Doses of ECHO 9  Virus, 
Strain "A. B." 
Material inoculated 
KP  1 ..................... 
KP 1-MP 2 .............. 
Effect  in mice of indicated age 
TCD•  inoculated 
Log 10 
<lday  $ to 5 days 
7.0  11/11 
6.0  16/16 
0/16 
0/16 
most of the virus particles multiply "slowly" the initial inoculum has to be 
large; if the majority of particles multiply more rapidly a paralytogenic effect 
can be achieved with a smaller dose. 
Behavior of the Prototype  (Hill) Strain  of ECHO 9  Virus in Newborn Mice 
Repeated tests with this strain failed to produce paralysis in newborn mice 
even with maximal doses of l0  T  TCD60 per mouse. Accordingly it was important 
to determine whether or not inapparent multiplication of this virus could be 
demonstrated in mice. Each of 18 newborn mice received 104.7 TCD6o of the 
Hill strain (0.02 ml. intracerebrally and 0.05 ml. subcutaneously) and 2 mice 
were sacrificed at  72  hours and  at  216 hours  (Table X).  None of the mice 
developed paralysis, and the amounts of virus recovered at the indicated times 
indicated that there was no progressive multiplication. In order to determine 
whether minimal multiplication may have occurred it was necessary to sacrifice 
mice at more frequent intervals to detect a  possible rise in virus yield after 
the initial fall. Such an experiment was carried out with an inoculum of 104 .5 
TCDs0 per mouse,  and  the results are shown in Table X  side by side with 
those obtained in a  similar test with a  multiplying strain of ECHO 9  virus 
(same as data used for Fig.  1).  The difference in the two "growth curves" is H. J. EGGERS  AND  A. B. SABIN  963 
clearly evident. To begin with it may be noted that the initial disappearance 
of about 98 per cent observed with  the A. B.  strain at 8 hours did not take 
place with  the  Hill  strain.  This  indicates  that unlike  the  multiplying A.  B. 
strain,  which  adsorbed  to  the  susceptible  cells  and  went  into  the  "eclipse" 
phase,  the Hill virus even failed to adsorb.  During the subsequent hours the 
A.  B.  strain  began to multiply,  while  the Hill  strain  progressively lost  titer 
presumably owing to deterioration in the mice. Thus it is possible to conclude 
TABLE X 
Difference in Growth Curves of Non-Mouse-Pathogeni~ (Hill) and Mouse-Palhogen~ ("A. B.") 
Variants of ECHO 9 Virus 
Time of harvest 
/tt$. 
0 
4 
8 
12 
18 
24 
48 
72 
168 
216 
Log I0 TCD~0 of virus per mouse recovered at indicated time after 
inoculation  of indicated strain and dose 
Hill  "A. B."* 
3.7  4.5  4.0 
3.2 
<1.0 
4.3 
4.3 
4.0 
3.6 
2.7 
2.2 
1.8 
1.7 
<1.0 
<1.0 
2.7 
2.3 
2.6 
3.0 
4.5 
4.6 
7.8 
6.8 
* First passage monkey tissue culture fluid of strain "A. B." was used. None of the sacri- 
riced mice exhibited paralysis and only 1 of 27 mice remaining at 8 days developed paralysis 
on 8th day and none thereafter. 
that  the  prototype ECHO  9  strain  not  only does  not  multiply in  newborn 
mice but also is not specifically adsorbed by the tissues. 
Multiplication in Newborn Mice of ECHO 9 Strains Recovered during 
Non-Epidemic Periods 
Besides the prototype strain the 2nd to 4th tissue culture passage of 7 other 
ECHO  9  strains  recovered from healthy children  in  Cincinnati  and  Mexico 
had  been  tested  in  our  laboratory for mouse pathogenicity  (5).  No paresis 
in any of the mice inoculated could be observed. The inocula of all these strains, 
however, ranged only from 102.° to 104.~ TCD60 per mouse. 
Subsequently, 3 of these  7 strains as well  as the Ouigley strain  which had 964  VARIANTS OF ECHO 9  VIRUS 
been found non-paralytogenic for mice (4), were tested for inapparent multi- 
plication in mice (Table XI). Three whole mice from each group were pooled 
and tested 5  to  10 days after inoculation of the indicated amounts of virus. 
The Daniels and ABV 20 strains  apparently did not multiply in mice. The 
BVA 84 strain exhibited a limited capacity for multiplication, while it remained 
doubtful whether the Quigley strain multiplied or not. 
It should be noted, however, that a strain of virus that was isolated from a 
healthy child during the winter of 1958 in New York (Sabin and Barnes, un- 
published data)  was  highly paralytogenic for newborn mice inoculated with 
106-s TCD56. 
TABLE XI 
Absent or Limited Multiplicallon in Newborn Mice of ECHO 9 Strains Recgoered during 
Non-Epidemic Periods 
Source 
Healthy children 
Aseptic meningitis 
Strain 
Place 
Cincinnati 
Mexico 
West Virginia 
Name 
Daniels 
ABV 20 
BVA 84 
Quigley 
Inoculum 
Log io  Tissue culture  TCDs0 
passage  per mouse 
KP 4  3.1 
KP 3  4.1 
KP 3  4.3 
Cinci KP 2  5.3 
Log 10 TCDss 
of virus per 
mouse sacrificed 
on indicated 
day after  inocu- 
I  lation 
•  r 
<1.5  <1.7 
<1.51  <1.7 
4.61  3.0 
3.1  <1.7 
DISCUSSION 
The  present  study  revealed  the  following  significant  factors  about  the 
pathogenicity for newborn mice of various strains of ECHO 9 virus:-- 
1.  Some strains, of which the prototype Hill strain is an example, not only 
fail to produce paralysis in maximal doses but also cannot multiply in or be 
adsorbed by the tissues of newborn mice. 
2.  Many naturally occurring strains  can multiply  to a  varying extent in 
newborn  mice  with  the  production  of  only rare  lesions  in  isolated  muscle 
fibers but without clinically apparent weakness or paralysis. 
3.  The virus  must  be capable of multiplying to  a  certain high  level  (1@ 
TCDs0 or more per mouse) within a specified time, which is 4 days after inocu- 
lation of mice less than 1 day old, for paralysis to appear. This is due to the 
fact that at 5 to 6 days of age there is a  change in the susceptibility to large 
doses of virus. 
4.  If the dose is too small or the rate of vires multiplication is too slow to 
achieve the necessary muscle involvement within the specified time, no weak- H.  J.  EGGERS  AND  A.  B.  SABIN  965 
ness  or paralysis  appears.  Conversely paralysis  occurs  if  the  initial  dose is 
large, such as can be achieved by preliminary propagation in tissue culture, 
and if the virus possesses the ability to multiply in the mouse. 
5.  Mere propagation in  tissue  culture did  not  alter  the  paralytogenic ac- 
tivity of the virus beyond increasing the dose that can be inoculated. On the 
other hand, passage in mice resulted in a gradual enrichment of virus particles 
capable  of  more  rapid  multiplication  in  mice  and  in  concurrent  greater 
paralytogenic activity of smaller doses. 
It has been suggested (17) that virulence for newborn mice may be a special 
property of ECHO  9  strains  derived from patients.  However,  the  Quigley 
strain derived from a patient with aseptic meningitis yielded data which indi- 
cated that it was incapable of multiplication in mice, while a  strain that we 
recovered from a healthy child in the winter of 1958 was entirely comparable 
to  the  paralytogenic,  epidemic  strains.  It  seems  to  us  more  important  to 
stress the fact that even the epidemic strains of ECHO 9 virus vary greatly 
in their capacity for multiplication in newborn mice, and that with very few 
exceptions only very large amounts of virus, such as are not usually encountered 
in human  specimens,  are  capable of producing paralysis.  Dr.  J.  H.  S.  Gear 
(personal communication) observed paralysis in one of 7 newborn mice inocu- 
lated with a  fecal suspension from a  boy with aseptic meningitis.  Serial pas- 
sage in mice was readily accomplished and the agent was identified as ECHO 
9.  In  the  light  of our studies  Gear's  unique  finding may be  interpreted as 
indicating that the human specimen probably had an unusually high concen- 
tration of virus, for in the absence of quantitative data one cannot estimate 
the virulence of the virus for mice. 
There has been considerable discussion  (17-21) as to whether the capacity 
of some strains of ECHO 9 virus to multiply in the muscles of newborn mice 
and with very large doses to produce paralysis in them, warrants a  reclassifi- 
cation of ECHO  9  with  the  Coxsackie A  viruses.  Instead  of attempting  to 
classify viruses on the basis of a  single character,  especially one so variable 
as pathogenicity, that may or may not be present in all members of the species, 
it seems to us better to recognize that in a  family of related viruses the pre- 
dominant  characteristic  of  one  group  may  be  present  to  a  limited  degree 
among  variants  of other groups.  Accordingly the  creation of the  family of 
enteroviruses (20) to include the ECHO, Coxsackie, and polioviruses appears 
to us a more appropriate solution of the problem. Otherwise we shall have to 
reclassify every Coxsackie and ECHO virus, with some capacity to produce 
neuronal lesions in monkeys, as new types of poliovirus. 
SUMMARY 
While some strains of ECHO 9 virus were found to be completely incapable 
of multiplying in  newborn mice or  even of being adsorbed  by their tissues 
(e.g.,  the  prototype  Hill  strain),  other  naturally  occurring  strains  readily 966  VARIANTS O~' ECHO 9  VIRUS 
multiplied even after inoculation of as little as 3  TCDs0 of virus.  With the 
multiplying strains, the infection remained clinically inapparent except after 
inoculation of very large doses,  usually in the range of 106 to  107.5 TCD6o. 
Investigation of the question why such large doses were required to produce 
paralysis  indicated  that  for paralysis  to  occur  virus  multiplication had  to 
reach a level of 108 TCDs0 or more within 4 days after inoculation of mice less 
than 1 day old. The reason for this was found in the fact that at 5 to 6 days 
of age the mice lost their susceptibility to paralysis even when multiplication 
was capable of progressing to the indicated high level. Thus, speed of multiplica- 
tion and extent of muscle involvement before the 5th day of life were  the 
determining factors. Passage in tissue culture had no effect except to yield a 
larger  dose  for  inoculation,  while  serial  propagation  in  mice  resulted  in  a 
gradual enrichment of virus particles capable of more rapid multiplication in 
mice and in a concurrent greater paralytogenic activity of smaller doses. 
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